Cancer-associated cachexia
- PMID: 29345251
- DOI: 10.1038/nrdp.2017.105
Cancer-associated cachexia
Abstract
Cancer-associated cachexia is a disorder characterized by loss of body weight with specific losses of skeletal muscle and adipose tissue. Cachexia is driven by a variable combination of reduced food intake and metabolic changes, including elevated energy expenditure, excess catabolism and inflammation. Cachexia is highly associated with cancers of the pancreas, oesophagus, stomach, lung, liver and bowel; this group of malignancies is responsible for half of all cancer deaths worldwide. Cachexia involves diverse mediators derived from the cancer cells and cells within the tumour microenvironment, including inflammatory and immune cells. In addition, endocrine, metabolic and central nervous system perturbations combine with these mediators to elicit catabolic changes in skeletal and cardiac muscle and adipose tissue. At the tissue level, mechanisms include activation of inflammation, proteolysis, autophagy and lipolysis. Cachexia associates with a multitude of morbidities encompassing functional, metabolic and immune disorders as well as aggravated toxicity and complications of cancer therapy. Patients experience impaired quality of life, reduced physical, emotional and social well-being and increased use of healthcare resources. To date, no effective medical intervention completely reverses cachexia and there are no approved drug therapies. Adequate nutritional support remains a mainstay of cachexia therapy, whereas drugs that _target overactivation of catabolic processes, cell injury and inflammation are currently under investigation.
Similar articles
-
Cancer Cachexia: Definition, Staging, and Emerging Treatments.Cancer Manag Res. 2020 Jul 9;12:5597-5605. doi: 10.2147/CMAR.S261585. eCollection 2020. Cancer Manag Res. 2020. PMID: 32753972 Free PMC article. Review.
-
Tumor cell anabolism and host tissue catabolism-energetic inefficiency during cancer cachexia.Exp Biol Med (Maywood). 2022 May;247(9):713-733. doi: 10.1177/15353702221087962. Epub 2022 May 6. Exp Biol Med (Maywood). 2022. PMID: 35521962 Free PMC article.
-
Revisiting Cancer Cachexia: Pathogenesis, Diagnosis, and Current Treatment Approaches.Asia Pac J Oncol Nurs. 2021 Aug 27;8(5):508-518. doi: 10.4103/apjon.apjon-2126. eCollection 2021 Sep-Oct. Asia Pac J Oncol Nurs. 2021. PMID: 34527780 Free PMC article. Review.
-
Barriers to cancer nutrition therapy: excess catabolism of muscle and adipose tissues induced by tumour products and chemotherapy.Proc Nutr Soc. 2018 Nov;77(4):394-402. doi: 10.1017/S0029665118000186. Epub 2018 Apr 30. Proc Nutr Soc. 2018. PMID: 29708079 Review.
-
Nutritional support in multimodal therapy for cancer cachexia.Support Care Cancer. 2008 May;16(5):447-51. doi: 10.1007/s00520-007-0388-7. Epub 2008 Jan 15. Support Care Cancer. 2008. PMID: 18196284 Review.
Cited by
-
Network pharmacology and molecular docking analysis reveal insights into the molecular mechanism of shiliao decoction in the treatment of cancer-associated malnutrition.Front Nutr. 2022 Aug 25;9:985991. doi: 10.3389/fnut.2022.985991. eCollection 2022. Front Nutr. 2022. PMID: 36091226 Free PMC article.
-
Regulation of Skeletal Muscle Atrophy in Cachexia by MicroRNAs and Long Non-coding RNAs.Front Cell Dev Biol. 2020 Sep 15;8:577010. doi: 10.3389/fcell.2020.577010. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33043011 Free PMC article. Review.
-
Sex Differences in Cancer Cachexia.Curr Osteoporos Rep. 2020 Dec;18(6):646-654. doi: 10.1007/s11914-020-00628-w. Epub 2020 Oct 12. Curr Osteoporos Rep. 2020. PMID: 33044689 Free PMC article. Review.
-
Myogenic microRNAs as Therapeutic _targets for Skeletal Muscle Mass Wasting in Breast Cancer Models.Int J Mol Sci. 2024 Jun 18;25(12):6714. doi: 10.3390/ijms25126714. Int J Mol Sci. 2024. PMID: 38928418 Free PMC article. Review.
-
Baoyuan Jiedu decoction alleviating cancer cachexia-Induced muscle atrophy by regulating muscle mitochondrial function in Apc Min/+ mice.Front Pharmacol. 2022 Aug 19;13:914597. doi: 10.3389/fphar.2022.914597. eCollection 2022. Front Pharmacol. 2022. PMID: 36060011 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources